Regulatory Focus on Nanomedicines in US and Europe

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

This article aims to produce an overview of nanotechnology and
its drug delivery systems, as well as the regulatory approach for
the approval of nanomedicines in regulated markets like the United
States and Europe. The use of nanoscale technologies to design
novel drug delivery systems and devices is a rapidly developing
area that promises breakthrough advances in therapeutics and
diagnostics. Nanomedicine is one area of nanotechnology, and
the goal of nanomedicine is to provide the most effective treatment
without side-effects. Vidhya Sabbella, Valluru Ravi, Prof. T. M.
Pramod Kumar and Sreekanth Reddy Kaja at JSS College submit
a new white paper on the regulatory focus on nanomedicines in the
US And Europe.
https://international-pharma.com/wp-content/uploads/2016/07/Drug-1-Regulatory-Focus.pdf